AC

Arindam Chakraborty

Director Director DIN 07805830
DIN 07805830 First appointment May 2017 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Arindam Chakraborty

Data last updated:

Arindam Chakraborty was a Director at Medright Biogenics Private Limited (2017–2019) and Director at Roll Bonkers Private Limited (from 2017). The companies operate in Chemicals.

DIN 07805830
Primary Designation Director
Industry Chemicals
First Appointment 29 May 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medright Biogenics Private Limited U24100WB2017PTC221242
Director29 May 20172017₹48.5 Lakh (FY 2024)Active
Roll Bonkers Private Limited U15127WB2017PTC221404
Director07 Jun 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Roll Bonkers Private Limited
Medright Biogenics Private Limited
Premium access

Shareholding and investment profile for Arindam Chakraborty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arindam Chakraborty

Arindam Chakraborty was first appointed on 29 May 2017 as Director at Medright Biogenics Private Limited.

Arindam Chakraborty held 2 earlier board appointments: Medright Biogenics Private Limited (Director, 29 May 2017 to 23 May 2019); Roll Bonkers Private Limited (Director, from 07 Jun 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available